Antimet Injection

About Antimet 10 mg/2 ml Injection

Antimet is an injection made by Square Pharmaceuticals PLC. It contains Metoclopramide Hydrochloride 10 mg/2 ml and belongs to the anti-emetic group of medicines. It is given by a healthcare professional, and the doctor decides the dose and course.

There are 19 brands of Metoclopramide Hydrochloride listed in Bangladesh. The lowest listed price is Motilon 10 mg Tablet at ৳ 0.34 per unit.

What is Antimet 10 mg/2 ml Injection?

Antimet is an anti-emetic injection produced by Square Pharmaceuticals PLC. Its active ingredient is Metoclopramide Hydrochloride, supplied as 10 mg/2 ml. Metoclopramide works on dopamine receptors and, at higher doses, on serotonin receptors in the brain area that triggers nausea and vomiting. It also affects movement in the upper gut, helping the stomach empty and increasing the tone of the lower food-pipe valve. Because it is an injection, it is given by a doctor or nurse, not by the patient at home. The dose and course are set by the doctor after assessing the patient.

Uses of Antimet

Antimet is used in adults for certain stomach and gut problems. Documented gastroesophageal reflux that has not responded to usual therapy may be treated for a limited period. It is also used for symptoms of acute and recurrent diabetic gastroparesis, a condition where the stomach empties slowly in people with diabetes. Because it is an injection, it is used where a doctor judges an injectable form is appropriate. Ask the doctor what the medicine is being given for in a particular case.

How to use Antimet

Antimet injection is given by a doctor or nurse, usually in a clinic or hospital setting. It is not meant for the patient to inject at home. The doctor decides the dose, how often it is given and how long the course lasts, based on the patient's condition and age. Tell the medical team about any other medicines being taken and about any past reactions to medicines before the injection is given.

Side effects of Antimet

The most common side effects reported with metoclopramide are changes in taste, headache and tiredness. Other effects can occur, including movement-related symptoms such as tardive dyskinesia and other extrapyramidal symptoms, and a serious reaction called neuroleptic malignant syndrome. Depression and thoughts of self-harm have also been reported. If any unusual symptoms appear after the injection, tell the doctor or nurse straight away so the medicine can be reviewed.

Safety and precautions

Antimet should not be used in people with a history of tardive dyskinesia or a dystonic reaction to metoclopramide, or with allergy to it. It is also avoided where stimulating gut movement could be dangerous, such as bleeding, blockage or perforation of the gut, and in people with pheochromocytoma or other catecholamine-releasing tumours, epilepsy, or Parkinson's disease. It should not be combined with other drugs that cause similar movement or nervous-system reactions, and it is avoided in depression or suicidal thoughts. Use in pregnancy only if clearly needed; it passes into breast milk, so nursing mothers should ask the doctor first. Anyone with these conditions should tell the doctor before treatment.

Frequently asked questions

What does the generic name Metoclopramide Hydrochloride mean?

Metoclopramide Hydrochloride is the active substance in Antimet. It is the generic, non-brand name of the medicine, while Antimet is the brand name used by Square Pharmaceuticals PLC. Metoclopramide belongs to the anti-emetic group and acts on dopamine and serotonin receptors.

What is Antimet used for and what kind of medicine is it?

Antimet is an anti-emetic injection containing Metoclopramide Hydrochloride 10 mg/2 ml. It is used in adults for documented gastroesophageal reflux that has not responded to usual therapy, and for symptoms of acute and recurrent diabetic gastroparesis. The doctor will explain whether it suits a particular patient.

How should Antimet be taken?

Antimet is an injection, so it is given by a doctor or nurse, not self-administered. The doctor decides the dose, how often it is given and how long the course lasts. Ask the doctor or pharmacist about anything you are unsure of, and report any side effects after the injection.

Who should ask a doctor before receiving Antimet?

People with a history of tardive dyskinesia or dystonic reactions, epilepsy, Parkinson's disease, pheochromocytoma or other catecholamine-releasing tumours, gut bleeding, blockage or perforation, or depression should tell the doctor first. Pregnant women and nursing mothers should also speak to the doctor, who will decide if it is suitable.

Indications

Metoclopramide nasal spray: This is a dopamine-2 (D2) antagonist indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.

Metoclopramide tablet:
  • This is indicated in the treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy.
  • ... Read more
Metoclopramide nasal spray: This is a dopamine-2 (D2) antagonist indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.

Metoclopramide tablet:
  • This is indicated in the treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy.
  • Relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
Metoclopramide Injection:
  • Diabetic Gastroparesis (Diabetic Gastric Stasis): Metoclopramide Injection is indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis.
  • The Prevention of Nausea and Vomiting Associated with Emetogenic Cancer Chemotherapy: Metoclopramide Injection is indicated for the prophylaxis of vomiting associated with emetogenic cancer chemotherapy.
  • The Prevention of Postoperative Nausea and Vomiting: Metoclopramide Injection is indicated for the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable.
  • Small Bowel Intubation: Metoclopramide Injection may be used to facilitate small bowel intubation in adults and pediatric patients in whom the tube does not pass the pylorus with conventional maneuvers.
  • Radiological Examination: Metoclopramide Injection may be used to stimulate gastric emptying and intestinal transit of barium in cases where delayed emptying interferes with radiological examination of the stomach and/or small intestine.

Pharmacology

Metoclopramide blocks dopamine receptors and in higher doses, it also blocks serotonin receptors in chemoreceptor trigger zone of the CNS. It enhances the response to acetylcholine of tissue in upper GI tract causing enhanced motility and accelerated gastric emptying w/o stimulating gastric, biliary, or pancreatic secretions. It also increases lower esophageal sphincter tone.

Dosage & Administration

Metoclopramide Spray:

Adults less than 65 years of age: The recommended dosage is 1 spray (15 mg) in one nostril, 30 minutes before each meal and at bedtime (maximum of 4 sprays daily) for 2 to 8 weeks, depending on symptomatic response.

Adults 65 years of age and older: Metoclopramide is not recommended in geriatric patients as initial therapy. Geriatric patients receiving an alternative metoclopramide product at a stable dosage of 10 mg four times daily can be switched to Metoclopramide 1 spray (15 mg) in one nostril, 30 minutes before each meal and at bedtime (maximum four times daily) for 2 to 8 weeks, depending on symptomatic response.

Metoclopramide tablet:

Gastroesophageal Reflux: Administer Metoclopramide continuously or intermittently:
  • Continuous: Administer 10 to 15 mg, 30 minutes before each meal and at bedtime (maximum of 60 mg per day) for 4 to 12 weeks.
  • Intermittent: Single doses up to 20 mg prior to provoking situation.
Acute and Recurrent Diabetic Gastroparesis: Administer 10 mg, 30 minutes before each meal and at bedtime (maximum of 40 mg per day) for 2 to 8 weeks.

Metoclopramide injection:

For the Relief of Symptoms Associated with Diabetic Gastroparesis (Diabetic Gastric Stasis): If only the earliest manifestations of diabetic gastric stasis are present, oral administration of metoclopramide may be initiated. However, if severe symptoms are present, therapy should begin with Metoclopramide Injection (IM or IV). Doses of 10 mg may be administered slowly by the intravenous route over a 1- to 2-minute period. Administration of Metoclopramide Injection (metoclopramide injection, USP) up to 10 days may be required before symptoms subside, at which time oral administration of metoclopramide may be instituted. The physician should make a thorough assessment of the risks and benefits prior to prescribing further metoclopramide treatment.

For the Prevention of Nausea and Vomiting Associated with Emetogenic Cancer Chemotherapy: Intravenous infusions should be made slowly over a period of not less than 15 minutes, 30 minutes before beginning cancer chemotherapy and repeated every 2 hours for two doses, then every 3 hours for three doses. The initial two doses should be 2 mg/kg if highly emetogenic drugs such as cisplatin or dacarbazine are used alone or in combination. For less emetogenic regimens, 1 mg/kg per dose may be adequate.

For the Prevention of Postoperative Nausea and Vomiting: Metoclopramide Injection should be given intramuscularly near the end of surgery. The usual adult dose is 10 mg; however, doses of 20 mg may be used.

Contraindications

Metoclopramide is contraindicated:
  • In patients with a history of tardive dyskinesia (TD) or a dystonic reaction to metoclopramide.
  • When stimulation of gastrointestinal motility might be dangerous (e.g., in the presence of gastrointestinal hemorrhage, mechanical obstruction, or perforation).
  • In patients with pheochromocytoma or other catecholamine-releasing paragangliomas. Reglan may cause a hypertensive/pheochromocytoma crisis, probably due to release of catecholamines from the tumor.
  • In patients with epilepsy. Reglan may increase the frequency and severity of seizures.
  • In patients with hypersensitivity to metoclopramide. Reactions have included laryngeal and glossal angioedema and bronchospasm.

Side Effects

Most common adverse reactions (≥5%) are: dysgeusia, headache, and fatigue.

Pregnancy & Lactation

Pregnancy Category B. Reproduction studies performed in rats, mice and rabbits by the IM, IV, subcutaneous (SC), and oral routes at maximum levels ranging from 12 to 250 times the human dose have demonstrated no impairment of fertility or significant harm to the fetus due to metoclopramide. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Nursing Mothers: Metoclopramide is excreted in human milk. Caution should be exercised when metoclopramide is administered to a nursing mother.

Precautions & Warnings

Tardive Dyskinesia (TD), Other Extrapyramidal Symptoms (EPS), and Neuroleptic Malignant Syndrome (NMS): Avoid concomitant use of other drugs known to cause TD/EPS/NMS and avoid use in patients with Parkinson’s Disease. If symptoms occur, discontinue Reglan and seek immediate medical attention.  

Depression and suicidal ideation/suicide: Avoid use.

Storage Conditions

Store between 20-25°C. Protect from light.

Alternative brands of Metoclopramide Hydrochloride

Other brands with the same generic name, cheapest first.

See all 19 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.